Pre-exposure chemoprophylaxis for HIV: it is time - Wikidata - wikimedia - TriplyDB

Pre-exposure chemoprophylaxis for HIV: it is time

Pre-exposure chemoprophylaxis for HIV: it is time

http://www.wikidata.org/entity/Q24792802

about

Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations.Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?Willingness to use pre-exposure prophylaxis for HIV prevention among female sex workers: a cross-sectional study in China.Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells.

P2860

Q24241184-68E35E81-47E3-4797-9611-3891DB3EAC36 Q28741736-5A209AF9-7457-4617-80D1-CCF1DCF49ED7 Q33332191-067D410F-7750-49B4-A70D-EF751CCCB3E8 Q34737582-E3AAB1A8-CF75-46EC-AEB4-3CFCE5A6C34C Q34989216-A626AE9F-CE4A-49CF-8439-8AFB66FF9266 Q35033732-724C6A67-B86D-4160-8654-42FBC66F83F0 Q36294982-AE1FE9F5-CC51-4860-A44A-E286CE4B848C Q37095750-455FADFF-192B-47B5-B838-73B0CFDFD64F

P2860

Pre-exposure chemoprophylaxis for HIV: it is time

http://www.wikidata.org/entity/Q24792802

description

2004 nî lūn-bûn

@nan

2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Pre-exposure chemoprophylaxis for HIV: it is time

@ast

Pre-exposure chemoprophylaxis for HIV: it is time

@en

Pre-exposure chemoprophylaxis for HIV: it is time

@nl

type

label

Pre-exposure chemoprophylaxis for HIV: it is time

@ast

Pre-exposure chemoprophylaxis for HIV: it is time

@en

Pre-exposure chemoprophylaxis for HIV: it is time

@nl

prefLabel

Pre-exposure chemoprophylaxis for HIV: it is time

@ast

Pre-exposure chemoprophylaxis for HIV: it is time

@en

Pre-exposure chemoprophylaxis for HIV: it is time

@nl

P1433

Q24792802-32EA99C9-9DDC-4707-AF98-2EE24ED97A89

P1476

Q24792802-B8295D1B-78A8-4232-982A-CEF6B35E12E4

P2093

Q24792802-0374B503-852B-41E7-A033-D8EBFA00ED2D

P2860

Q24792802-092C34F4-CD5A-45A6-B554-3D62787AB8E7

Q24792802-0E48393A-4136-476D-B54B-7AE0441F53EC

Q24792802-1211ECC8-9028-4D04-9F2E-9A63BA4AF8C8

Q24792802-14A649D7-A524-4827-86DA-FB7A2D2831D8

Q24792802-2C9BA9AF-EE10-46CB-B0FE-A689EA1862A9

Q24792802-355EF616-2A73-4F01-8E23-4C078EEE03BA

Q24792802-3D8FE2BE-260B-4D1E-A47A-2616404BEE17

Q24792802-501751AC-45DC-4AEF-95E5-7AD326E76FE7

Q24792802-51B797AF-86CE-4D9A-B777-9279EF2B657E

Q24792802-65D0F7B3-219F-400D-9F66-F80D6883FB88

P2888

Q24792802-4DEB5F01-0D8D-4131-B3D4-810C8028F28C

P304

Q24792802-FDD16904-B5B2-49D0-AEEA-182FC7B3A69A

P31

Q24792802-29B3BB2F-B51C-445A-A98C-E8BC63B9EEFA

Q24792802-73A0C7BB-E944-40CF-BF2F-ADFD7E1E1FBF

P356

Q24792802-7E7B6851-7F78-461C-BE25-D46E4C707F73

P407

Q24792802-47290678-CBA1-40B9-A979-60F96F7E9F49

P433

Q24792802-9A700758-AD76-4E73-A53E-6D657714D74B

P478

Q24792802-33BA4EAD-CD8C-4C07-8E34-65315C935EA7

P577

Q24792802-FF83CE60-A2E7-4677-A387-C918A9A5A29D

P5875

Q24792802-A4B2C43D-7397-40EA-A149-AF1292DB65DC

P6179

Q24792802-527760EF-2A39-45C5-8090-247DA978606A

P698

Q24792802-7007996A-FB45-4460-BB78-B185F35AE1FE

P921

Q24792802-DEA6B2C7-134F-4901-8234-10465B104F5D

P932

Q24792802-C2096BA0-9642-44C2-AF7E-A1B3A00CBA25

P356

P1433

P1476

Pre-exposure chemoprophylaxis for HIV: it is time

@en

P2093

Stephen M Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse effects of antiretroviral therapy for HIV infection

HIV CTL escape: at what cost?

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment

HIV therapeutics: past, present, and future.

Public health. A sound rationale needed for phase III HIV-1 vaccine trials.

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

Accomplishments in HIV prevention science: implications for stemming the epidemic.

Updated recommendations for reducing vertical HIV transmission.

Zidovudine: five years later.

P2888

P304

16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4690-1-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8471187

http://www.w3.org/2001/XMLSchema#string

P6179

1010700245

http://www.w3.org/2001/XMLSchema#string

P698

15238164

http://www.w3.org/2001/XMLSchema#string

P921

P932

478616

http://www.w3.org/2001/XMLSchema#string